The electronics manufacturing sector, once a favorite of assertive investors, has become more challenging with maturity. With a small number of entrenched suppliers and high barriers to entry, innovative business models have become as important as innovative technology, and it is rare to find both under one roof.

Alchimer’s mission has always been to find a way to profitably bring new manufacturing technology to a range of markets.

We chose early on to avoid hardware manufacturing, and designed our proprietary Electrografting (eG™) and Chemicalgrafting (cG™) processes to run on widely available industry-standard wet benches.

While our technology is delivered in the form of consumable chemicals, we do not manufacture them, preferring to partner with well-established suppliers with site synergy in strategic markets. This allows our R&D team to focus on the most critical aspect of wet-deposition technology – creating robust materials that exceed current industry norms.

Our revenue stream comes from a combination of up-front licenses and ongoing royalties, which grow over time as our process is adopted into a wide range of applications in electronic packaging, wafer fabrication, alternative energy, and other sectors.

Result: our customers are freed from the restrictions of the traditional production equipment market, our costs are kept to a minimum, and our revenue stream is linked directly to usage.